MMS reaches an employee training milestone of 700 pharma industry courses
Posted on 4/13/2018
Canton, Mich. (April 13, 2018) – MMS Holdings Inc. (MMS) – a global, leading clinical research organization – announced today that it has surpassed a training milestone, now with more than 700 training courses available in their learning management system. This platform offers education to all MMS colleagues across North America, Europe, India, and South Africa in a variety of formats from instructor led to self-directed sessions.
Each of the courses has been developed in-house, and expertise in the data sciences and clinical research arenas has led MMS to provide training outside of the organization to research sponsor teams as well. MMS staff provides training to sponsors on New Drug Application (NDA) submissions planning and best practices, as well as clinical trial disclosure topics on a routine basis, among other training.
“One of our most important assets is the people that work at MMS throughout the world, with their data and science–first mindset and unmatched drive to meet our customer’s needs,” said Michelle Gayari, Head of Global Operations, MMS. “From the onset, MMS has been an organization focused on compliance and strength of process, and a key component is supporting each colleague’s need to be continually learning and stretching within this fast-paced industry.”
To further this dedication to education and talent development within the research community and pharmaceutical and life sciences industries, the company created MMS University to serve the continuing education needs of students, recent graduates, and current working professionals.
“As an instructor, it is incredibly rewarding to be passing on nearly 30 years of industry knowledge,” said Chris Hurley, Senior Manager, Global Data Operations, Standards and Systems, MMS, and clinical programming instructor, MMS University. “Continual learning is a key trait for any effective leader, and we are proud to bring this to the future leaders in pharma.”
Beyond clinical programming, areas of focus include medical and regulatory writing, biostatistics, clinical trial disclosures, pharmacovigilance, use of real world evidence, and more.
Follow the MMS journey at https://www.linkedin.com/company/mms-holdings-inc-/
MMS is a global, leading clinical research organization that supports the pharmaceutical and biotech industries with a proven, scientific approach to complex regulatory submission challenges. As a data CRO, we are pioneers and leaders in regulatory submissions for our sponsors. Strong industry experience and a data-driven approach to drug development make MMS a valuable partner in creating compelling submissions that meet rigorous regulatory standards.
About MMS University
MMS University offers students and working professionals continuing education opportunities that enhance their skills and expertise. Providing both theory and hands-on experience, the courses offered educate students on the complexities and requirements for professionals in the medical writing, clinical programming and clinical trial disclosure disciplines. Created by subject matter experts and a leading global CRO, MMS University empowers students with the critical in-demand knowledge the pharmaceutical industry requires. For more information, visit: www.mmsuniversity.com.